|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 51/00 | |
| A61K 39/42 | |||
| A61K 39/40 | |||
| A61K 47/18 | |||
| A61K 47/42 |
| (11) | Patento numeris | 1729821 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05731866.9 |
| Europos patento paraiškos padavimo data | 2005-03-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-12-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-07-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/007524 |
| Data | 2005-03-03 |
| (87) | Numeris | WO 2005/084410 |
| Data | 2005-09-15 |
| (30) | Numeris | Data | Šalis |
| 550015 P | 2004-03-03 | US |
| (72) |
DAKE, Michael D., US
WAUGH, Jacob M., US
|
| (73) |
ReVance Therapeutics, Inc.,
2400 Bayshore Parkway, Mountain View CA 94043,
US
|
| (54) | COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |
| COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS |